Phase III clinical trials involve large groups of patients to confirm the drug’s efficacy, monitor side effects, compare it to standard treatments, and collect data to ensure the drug’s safe use. These trials provide the comprehensive evidence needed for regulatory approval. Successful Phase III trials can lead to the submission of a New Drug Application (NDA) or Biologics License Application (BLA).